J
Josep Rodés-Cabau
Researcher at Laval University
Publications - 712
Citations - 36080
Josep Rodés-Cabau is an academic researcher from Laval University. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 87, co-authored 610 publications receiving 29214 citations. Previous affiliations of Josep Rodés-Cabau include Hospital Clínico San Carlos & Claude Bernard University Lyon 1.
Papers
More filters
Journal ArticleDOI
Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation
A. Pieter Kappetein,Stuart J. Head,Philippe Généreux,Nicolo Piazza,Nicolas M. Van Mieghem,Eugene H. Blackstone,Thomas G. Brott,David Cohen,Donald E. Cutlip,Gerrit-Anne van Es,Rebecca T. Hahn,Ajay J. Kirtane,Mitchell W. Krucoff,Susheel Kodali,Michael J. Mack,Roxana Mehran,Josep Rodés-Cabau,Pascal Vranckx,John G. Webb,Stephan Windecker,Patrick W. Serruys,Martin B. Leon +21 more
TL;DR: This VARC-2 document has provided further standardization of endpoint definitions for studies evaluating the use of TAVI, which will lead to improved comparability and interpretability of the study results, supplying an increasingly growing body of evidence with respect to TAVi and/or surgical aortic valve replacement.
Journal ArticleDOI
Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
Jean-Pierre Després,Isabelle Lemieux,Jean Bergeron,Philippe Pibarot,Patrick Mathieu,Eric Larose,Josep Rodés-Cabau,Olivier F. Bertrand,Paul Poirier +8 more
TL;DR: Although waist circumference is a better marker of abdominal fat accumulation than the body mass index, an elevated waistline alone is not sufficient to diagnose visceral obesity and it is proposed that an elevated fasting triglyceride concentration could represent a simple clinical marker of excess visceral/ectopic fat.
Journal ArticleDOI
Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk: Acute and Late Outcomes of the Multicenter Canadian Experience
Josep Rodés-Cabau,John G. Webb,Anson Cheung,Jian Ye,Eric Dumont,Christopher M. Feindel,Mark Osten,Madhu K. Natarajan,James L. Velianou,Giuseppe Martucci,Benoit DeVarennes,Robert J. Chisholm,Mark D. Peterson,Samuel V. Lichtenstein,Fabian Nietlispach,Daniel Doyle,Robert DeLarochellière,Kevin Teoh,Victor Chu,Adrian Dancea,Kevin Lachapelle,Asim N. Cheema,David A. Latter,Eric Horlick +23 more
TL;DR: A TAVI program including both TF and TA approaches was associated with comparable mortality as predicted by surgical risk calculators for the treatment of patients at very high or prohibitive surgical risk, including porcelain aorta and frail patients.
Journal ArticleDOI
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.
Danny Dvir,John G. Webb,Sabine Bleiziffer,Miralem Pasic,Ron Waksman,Susheel Kodali,Marco Barbanti,Azeem Latib,Ulrich Schaefer,Josep Rodés-Cabau,Hendrik Treede,Nicolo Piazza,David Hildick-Smith,Dominique Himbert,Thomas Walther,Christian Hengstenberg,Henrik Nissen,Raffi Bekeredjian,Patrizia Presbitero,Enrico Ferrari,Amit Segev,Arend de Weger,Stephan Windecker,Neil Moat,Massimo Napodano,M. Wilbring,Alfredo Giuseppe Cerillo,Stephen Brecker,Didier Tchetche,Thierry Lefèvre,Federico De Marco,Claudia Fiorina,Anna Sonia Petronio,Rui Campante Teles,Luca Testa,Jean Claude Laborde,Martin B. Leon,Ran Kornowski +37 more
TL;DR: The survival of patients after transcatheter valve-in-valve implantation inside failed surgical bioprosthetic valves was determined and stenosis was worse than regurgitation among patients with structural valve deterioration.
Journal ArticleDOI
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
Jean-Claude Tardif,Jean Grégoire,Philippe L. L’Allier,Reda Ibrahim,Jacques Lespérance,Therese Heinonen,Simon Kouz,Colin Berry,Russell Basser,Marc-André Lavoie,Marie-Claude Guertin,Josep Rodés-Cabau,Efficacy (Erase) Investigators +12 more
TL;DR: Short-term infusions of reconstituted HDL resulted in no significant reductions in percentage change in atheroma volume or nominal change in plaque volume compared with placebo but did result in statistically significant improvement in the plaque characterization index and coronary score on quantitative coronary angiography.